An observational study in Neonatal Disorder, sponsored by Nationwide Children's Hospital. Completed at 1 site in United States. Open to participants aged Up to 36 Weeks. Per ClinicalTrials.gov, last updated 2020-02-17.
Sponsored by Nationwide Children's Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 43 studies in Infant, Newborn, Diseases with a site in United States — 3 open to participants now, 7 under way, 1 of them phase 3. Infant, Newborn, Diseases · United States.
Among the 43 studies in Infant, Newborn, Diseases with a site in United States, this one is one of 4 that started in 2017, is one of 9 observational ones, and was the 34th registered.
140 studies on the registry are indexed under Infant, Newborn, Diseases; 29 are open to participants now.
Browse Infant, Newborn, Diseases studies →3 of the 43 studies in Infant, Newborn, Diseases with a site in United States are open now. Recruiting first, the newest first:
Duke University · Sites in United States
Ages 0 days–9 mo
NICHD Neonatal Research Network · Sites in United States
Ages 1 hrs–48 hrs · Healthy volunteers
Washington University School of Medicine · Sites in United States
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 21 Infant, Newborn, Diseases studies recruiting now, 3 (14%) set no upper age limit and 18 (86%) stop at 75 or younger; 17 take children under 18; 5 take healthy volunteers.
This study: Up to 36 Weeks · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
43 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 10 · Phase 3 9
First in 1996; this study’s year is marked. 4 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 112 is above the median of 100 across 49 observational studies indexed under Infant, Newborn, Diseases.
Median enrollment 110 across the 32 interventional studies, 53 across the 8 observational. Of the 33 that completed or were terminated, 17 (52%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 43 have an industry lead sponsor. The 10 most frequent:
Nationwide Children's Hospital is the lead sponsor of 233 studies on the registry; 43 are open to participants now.
Of its 17 completed or terminated interventional studies of FDA-regulated products, 9 (53%) have results posted.
Nationwide Children's Hospital has 1 study filed under Infant, Newborn, Diseases — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 43 studies in Infant, Newborn, Diseases with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
In order to evaluate current anesthetic practice in the care of preterm infants and neonates, the investigators will retrospectively review surgical procedures in infants who are less than 60 weeks post-conceptual age in which an arterial cannula was placed intraoperatively or in situ upon arrival in the operating room. They will evaluate the mode of ventilation (pressure or volume-controlled), tidal volume or peak inflating pressure, the level of PEEP, inspired oxygen concentration (FiO2), and respiratory rate used during the procedure to determine the average minute ventilation.
Patients seen at Nationwide Children's Hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Decreased Partial Pressure of Carbon Dioxide (PaCO2)
PaCO2 from arterial blood gas (ABG) ≤ 35
Time frame: During surgical procedure (average of 2-3 hours)
Ran from Mar 2017 to primary completion in Nov 2019, 32 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nationwide Children's Hospital →